Regulatory Updates and Amendment of the Pharma Regulations in Japan

Duration - 38 Minutes

Price - INR-2000 / USD-70
Book Now   Enquire Now  

About the course

Key updates in the new regulation of Pharmaceuticals and Medical Devices Agency (PMD)
- Key points of the amendment of the PMD Act
- Future area of guidance D21
- Challenges and opportunities for industry to create favorable environment in expediting B21approval of medicines
- GMP developments and implementation of ICHQ3D in Japan
- Japanese Pharmacopoeia amendment JP18 and updates

Speaker Profile

Dr. M Madan Mohan Reddy

Vice President - Quality and Regulatory

Website by: Xpoteck